NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Gastrointestinal disease
Date of first enrollment	10/01/2012
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : ZO-Y60 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : 3 capsules / day

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 15age old
Age maximum	<= 64age old
Gender	Both
Include criteria	Patients with gasstrointestinal disease. Out-patients who signed a written informed consent. If patient age is under 20 years old, a written informed consent have to be obtained from both participant and his/her parent(s).
Exclude criteria